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Background: Dental caries and periodontal disease are the commonest bacterial diseases of man and can result in
tooth loss. The principal method of prevention is the mechanical removal of dental plaque augmented by active
agents incorporated into toothpastes and mouthrinses. In-vitro assays that include complex oral bacterial biofilms
are required to accurately predict the efficacy of novel active agents in vivo. The aim of this study was to develop
an oral biofilm model using the Calgary biofilm device (CBD) seeded with a natural saliva inoculum and analysed
by next generation sequencing. The specific objectives were to determine the reproducibility and stability of the
model by comparing the composition of the biofilms over time derived from (i) the same volunteers at different
time points, and (ii) different panels of volunteers.
Results: Pyrosequencing yielded 280,093 sequences with a mean length of 432 bases after filtering. A mean of 320
and 250 OTUs were detected in pooled saliva and biofilm samples, respectively. Principal coordinates analysis
(PCoA) plots based on community membership and structure showed that replicate biofilm samples were highly
similar and clustered together. In addition, there were no significant differences between biofilms derived from the
same panel at different times using analysis of molecular variance (AMOVA). There were significant differences
between biofilms from different panels (AMOVA, P < 0.002). PCoA revealed that there was a shift in biofilm
composition between seven and 14 days (AMOVA, P < 0.001). Veillonella parvula, Veillonella atypica/dispar/parvula
and Peptostreptococcus stomatis were the predominant OTUs detected in seven-day biofilms, whilst Prevotella oralis,
V. parvula and Streptococcus constellatus were predominant in 14-day biofilms.
Conclusions: Diverse oral biofilms were successfully grown and maintained using the CBD. Biofilms derived
from the same panel of volunteers were highly reproducible. This model could be used to screen both
antimicrobial-containing oral care products and also novel approaches aiming to modify plaque composition,
such as pre- or probiotics.
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Dental caries and the periodontal diseases are the com-
monest bacterial diseases of man and can result in the
loss of the teeth and their associated function, and are
also significant risk factors for disease at other body
sites, particularly cardiovascular disease [1]. Treatment
of oral diseases is expensive and efforts have therefore
focused on prevention, particularly through the use of
mouthrinses and toothpastes containing active agents* Correspondence: w.wade@qmul.ac.uk
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unless otherwise stated.that control the bacteria found in dental plaque. The
evaluation of novel active agents and formulations in
humans is time-consuming and difficult and toxico-
logical data may not be available for new compounds.
Consequently, attempts have been made to develop in-
vitro assays that accurately predict efficacy in vivo [2,3].
These assays enable researchers to perform preliminary
screening of active agents in order to identify candidates
for subsequent testing in clinical trials, wherein the
therapeutic effects, as well as issues such as substantiv-
ity in the oral cavity [4], can be determined.
Many existing in-vitro assays cultivate oral bacteria for
testing in planktonic suspension but it has been shown
that bacteria naturally form biofilms [5]. Bacteria inThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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than cells growing in planktonic culture [6,7]. In addition,
the composition of oral biofilms is typically highly complex
and includes a substantial number of species which have
yet to be cultivated [8]. Recent deep sequencing studies
have, for example, detected hundreds of species in dental
plaque samples from individual subjects [9-11]. Although
some in-vitro oral biofilm assays have been developed,
these have typically used relatively simple defined inocula
[12-15]. Given the high richness and diversity of oral bio-
films, it would be preferable to use natural inocula in order
to more accurately represent the in-vivo ecosystem.
One in-vitro system that has been previously developed
and used to grow bacteria as biofilms is the Calgary bio-
film device (CBD) [16]. In this system, biofilms are grown
on pegs protruding from the lid of a 96-well plate. The
pegs are immersed in a growth medium that can easily be
replaced by transferring the lid to a new baseplate, thereby
enabling the long-term growth of biofilms. The CBD
was originally developed to determine the susceptibility
of bacterial biofilms to antibiotics [16] for applications
such as medical device-related infections, and is there-
fore commercially available as the ‘Minimum Biofilm
Eradication Concentration’ (MBEC) assay (Innovotech,
Canada). Previous work has demonstrated that uniform
biofilms with reproducible total viable counts can be
obtained when using simple defined bacterial inocula
[17]. The CBD has also been used to examine the inter-
actions among five common oral species when grown
anaerobically for up to 36 hours [18]. Using quantitative-
PCR, the authors showed that Porphyromonas gingivalis
cell counts increased when grown together with a Veillo-
nella sp., Fusobacterium nucleatum, or Aggregatibacter
actinomycetemcomitans, suggesting mutualism between
these species.
The overall aim of this study was to develop an oral
microbial biofilm model derived from a natural inocu-
lum: the saliva of healthy individuals, using the CBD.
The biofilms thus generated will be suitable for assessing
the impact of different oral care product components on
oral biofilm composition. The specific aims of this study
were to determine the reproducibility, stability and vari-
ability of the model by using pyrosequencing of partial
16S rRNA genes to compare the composition of the bio-
films over time derived from saliva from (i) the same in-




Ethical approval for this study was granted by Queen
Mary University of London Ethics of Research Committee
(reference no. QMREC2013/58). Informed consent was
obtained from all of the individuals who participated. Allof the participants were between 18 and 65 years of age
and were medically healthy volunteers who were staff or
postgraduate students at Queen Mary University of
London. Any subjects with systemic conditions that
may have affected their immune or inflammatory status
were excluded from the study. A total of 18 subjects
participated in the study.
Sample collection
Un-stimulated saliva samples were obtained from the
participants by expectoration into sterile universal tubes.
Saliva was collected between approximately 14:30 and
15:00 on the days that the biofilms were to be inocu-
lated. Participants were grouped into panels of six and
their saliva samples pooled together in equal volumes:
1 ml was used from each individual to produce a 6 ml
pooled sample. Pooled saliva was placed on ice and proc-
essed within an hour. One panel was sampled at three dif-
ferent time points, a week apart, and two panels were
sampled at one time point.
Inoculation of the Calgary biofilm device
The saliva was vortexed for 15 s and 200 μl was pipetted
per well of a 96-well microplate, up to the required
number of wells. Wells around the outside of the micro-
plate were not used. The lid of the CBD was fitted onto
the microplate so that the hydroxyapatite-coated pegs
were bathed in the saliva. The CBD plate was then incu-
bated at 37°C under anaerobic conditions (80% N2, 10%
H2, and 10% CO2) for 18 hours, after which the lid was
transferred to a new baseplate containing 200 μl of pre-
reduced Brain Heart Infusion broth (Fluka Analytical)
growth medium supplemented with hog gastric mucin
(1 g/L), haemin (10 mg/L), and vitamin K (0.5 mg/L).
The growth medium was changed after every 3.5 days of
anaerobic incubation. Biofilms were harvested from half
of the pegs after seven days and from the remaining half
after 14 days.
Removal of pegs and propidium monoazide treatment of
samples
Pegs with biofilms were snapped off the lid with sterile
pliers and washed by dipping into sterile phosphate-
buffered saline (PBS) three times. All of the visible bio-
film material was then removed using a sterile curette
and suspended into 500 μl of sterile PBS. The material
from three pegs was pooled to produce one sample for
analysis, and three samples were processed for each incu-
bation time. Each sample, and half of the original saliva
sample, was subjected to propidium monoazide (PMA)
treatment to prevent subsequent PCR amplification of
extracellular DNA and DNA from dead or damaged cells
[19]: 1.25 μl of PMA was added (at a final concentration
of 50 μM) to the cells suspended in PBS and incubated in
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temperature. The samples were then exposed to light from
a 500 W halogen lamp for 5 mins at a distance of 20 cm
in order to form a covalent linkage between the PMA and
the DNA. During the exposure time the samples were
placed on ice to avoid excessive heating and subjected to
occasional shaking. The samples were used for DNA ex-
tractions immediately after the PMA treatment.
DNA extraction
DNA was extracted from the saliva and biofilm samples
using the GenElute Bacterial DNA extraction kit (Sigma-
Aldrich). Extractions were performed on both PMA-
treated and -untreated aliquots (500 μl) of pooled saliva
samples. DNA extraction was performed following the
manufacturer’s instructions with an additional cell lysis
step to increase the recovery of DNA from Gram-positive
cells, in which samples were incubated in a 45 mg/ml
lysozyme solution at 37°C for 30 mins.
Molecular microbiological analysis
The bacterial composition of the biofilms and saliva was
determined using 454 pyrosequencing of partial 16S rRNA
genes as described previously [11], with some minor mod-
ifications. PCR amplification of a fragment of the 16S
rRNA gene, approximately 500 bp in length covering the
V1-V3 hypervariable regions, was performed for each
DNA sample using composite fusion primers. The fu-
sion primers comprised the broad-range 16S rRNA gene
primers 27 FYM [20] and 519 R [21] along with Roche
GS-FLX Titanium Series adapter sequences (A and B)
for 454-pyrosequencing using the Lib-L emulsion-PCR
method. The forward primers included previously de-
scribed 12-base error-correcting Golay barcodes. PCR
reactions were performed using Extensor Hi-fidelity
PCR mastermix (Thermo-Scientific) along with the ap-
propriate barcoded forward primer and the reverse pri-
mer. The PCR conditions were as follows: 5 mins initial
denaturation at 95°C, followed by 25 cycles of 95°C for
45 s, 53°C for 45 s and 72°C for 45 s and a final exten-
sion of 72°C for 5 mins. PCR amplicons were then puri-
fied using the QIAquick PCR purification kit (Qiagen)
according to the manufacturer’s instructions. The size and
purity of the amplicons was checked using the Agilent
DNA 1000 kit and the Agilent 2100 Bioanalyzer. Quanti-
tation of the amplicons was performed by means of a
fluorometric assay using the Quant-iT Picogreen fluores-
cent nucleic acid stain (Invitrogen). The amplicons were
then pooled together at equimolar concentrations (1 × 109
molecules/μl). Emulsion-PCR and unidirectional sequen-
cing of the samples was performed using the Lib-L kit and
the Roche 454 GS-FLX + Titanium series sequencer by
the Department of Biochemistry, Cambridge University,
Cambridge, UK.The raw sequence data were deposited with the NCBI
SRA database as accession SRP051689.
Sequence analysis
Sequence analysis was performed using the ‘mothur’ soft-
ware suite version 1.33 [22], following the 454 standard
operating procedure [23] on mothur.org. The sequences
were denoised using the AmpliconNoise algorithm [24],
as implemented by mothur. Sequences that were less than
440 bases in length and/or had one of the following: >2
mismatches to the primer, >1 mismatch to the barcode
regions, and homopolymers of >8 bases in length, were
discarded. The remaining sequences were trimmed to re-
move primers and barcodes and aligned to the SILVA 16S
rRNA reference alignment [25]. The UChime algorithm
[26] was used to identify chimeric sequences, which were
then removed from the dataset. Sequences were clustered
into operational taxonomic units (OTUs) at a genetic dis-
tance of 0.015 using the average neighbour algorithm and
identified using a Naïve Bayesian classifier [27] with the
Human Oral Microbiome Database (HOMD) reference
set (version 13). For those OTUs that could not be identi-
fied using the Bayesian classifier, representative sequences
were obtained in mothur (the sequence with the smal-
lest distance to all other sequences in that OTU) and
identified using BLAST against the HOMD reference set
(version 13). The possible alternatives for the species
identification were then provided.
Analysis of alpha and beta diversity
The sequences for each sample were randomly sub-
sampled to the same number (that of the sample with the
lowest number of sequences: 3023) for the alpha and beta
diversity analyses. The extent of sampling of the commu-
nities was assessed using Good’s non-parametric coverage
estimator [28]. The diversity of the communities was cal-
culated using Simpson’s inverse diversity index [29]. The
beta-diversity of the samples was analysed using distance
matrices generated using the Jaccard index and the the-
taYC calculator [30]. The distance matrices were visualised
using principal coordinates analysis (PCoA) plots gener-
ated in R (r-project.org).
Statistical analysis
Analysis of molecular variance (AMOVA) [31], as imple-
mented in mothur, was used to determine if there were
statistically significant differences in Jaccard index and
thetaYC distances between saliva and biofilm samples
and between biofilms from different time points, subject
panels, and incubation times. The mean relative abun-
dances of phyla, genera, and species-level OTUs in biofilms
was determined as follows: The proportions of sequences
assigned to a particular taxon were calculated for biofilms
derived from different panels at a single time point only
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14-day incubations. The PMA-treated saliva samples were
used for statistical comparisons of the taxonomic compos-
ition of saliva to biofilms. To determine if there were sig-
nificant differences in OTU richness and diversity between
the incubation times, paired t-tests were performed in R.
Results
Pyrosequencing
A total of 232,757 sequences with a mean length of 432
bases were obtained for analysis after quality filtering,
screening of the sequence alignment, and removal of chi-
meras. A mean of 5968 sequences (range: 3023–7637) were
obtained per sample. One replicate biofilm sample derived
from Panel 1 after seven days of incubation (P1_T3_7D_c)
was not included in the sequencing run due to poor PCR
amplification. The number of OTUs (clustered at a dis-
tance of 0.015) detected in individual biofilm and pooled
saliva samples ranged between 195 and 391. The mean
number of OTUs detected was 250 in the biofilms and 320
in the saliva samples. A table summarising the alpha diver-
sity of the biofilms and saliva is shown in Additional file 1.
The number of OTUs detected in the seven-day biofilms
(mean = 270.4) was significantly higher (P < 0.003) than in
the 14-day biofilms (mean = 230.4). However, there was no
significant difference in diversity (Simpson’s inverse diver-
sity index) between the seven- and 14-day biofilms.
Reproducibility of biofilms and shifts in biofilm OTU
composition over time
Comparison of the community membership and structure
of biofilms using principal coordinates analysis (PCoA)
plots indicated that replicate biofilm samples, derivedFigure 1 Principal coordinates analysis of biofilms derived from differ
community membership using the Jaccard index (A) and community struc
black - Panel 3. Labels indicate the incubation time. A: PC1 = 8.6% of varian
of variance.from the same saliva pool after the same incubation time
but harvested from different pegs, were highly similar and
clustered together (Figure 1). In addition, biofilms derived
from the same panel (Panel 1) at different times were
similar (Figure 2) and AMOVA tests found there to be no
statistically significant difference between the time points.
However, there were significant differences in both the
membership and structure of biofilms derived from the
three different subject panels. The most significant differ-
ences by AMOVA were between biofilms from Panel 1
and Panel 3 (P = 0.001 for both membership and struc-
ture). Interestingly, PCoA indicated that the dissimilarity
in community structure between panels was greater after
14 days than after seven days (Figure 1).
There was a directional shift along the axes in the
PCoA plots between seven and 14 days of incubation for
biofilms derived from all three panels (Figures 1 and 2).
AMOVA confirmed that there was a significant differ-
ence between the 7-day and 14-day incubations both in
terms of membership and structure (P < 0.001 for both
comparisons). Analysis using LEfSe identified a total of
74 OTUs that were significantly differentially abundant
between incubation times. The identities of the OTUs
with LDA effect size scores of >3.5 are shown in Figure 3.
An OTU identified as Veillonella parvula was most
strongly associated with the 7-day incubations, whilst
Parvimonas micra was most strongly associated with
the 14-day incubations.
Hierarchical cluster analysis showed that the biofilm
samples clustered by panel in a dendrogram based on
community membership (Additional file 2) and predom-
inantly by incubation time in a dendrogram based on
structure (Additional file 3).ent panels after different incubation times. Plots are based on
ture using the thetaYC calculator (B). Blue - Panel 1; red - Panel 2;
ce, PC2 = 5.2% of variance. B: PC1 = 33.1% of variance, PC2 = 19.3%
Figure 2 Principal coordinates analysis of biofilm replicates from Panel 1 at different time points. Plots are based on community
membership using the Jaccard index (A) and community structure using the thetaYC calculator (B). Blue - Time 1; red - Time 2; black - Time 3.
A: PC1 = 8.6% of variance, PC2 = 5.2% of variance. B: PC1 = 33.1% of variance, PC2 = 19.3% of variance.
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Comparison of saliva samples with the biofilms using
PCoA plots revealed a differing community membership
and structure (Figure 4). AMOVA tests confirmed that
there were significant differences in both the membership
and structure of saliva compared to seven and 14-day bio-
films (P < 0.001 for both comparisons). Analysis using
LEfSe identified 112 OTUs that were significantly differen-
tially abundant between saliva and biofilms that had been
grown for seven days. A list of differentially abundant
OTUs with LDA effect size scores of >3.5 is shown in
Figure 5. An OTU identified as Neisseria flavescens/sub-
flava was most strongly associated with saliva, whilst
Veillonella parvula was most strongly associated with
the biofilms.Figure 3 Linear Discriminant Analysis Effect Size (LEfSe) analysis show
between seven- and 14-day incubation times, ranked by effect size (aComparison of PMA-treated and untreated saliva samples
Comparisons using PCoA showed that PMA-treated and
untreated saliva were similar and samples clustered by
the panel from which they were obtained, rather than by
treatment (not shown). There were no significant differ-
ences in community membership or structure between
PMA-treated and untreated saliva using AMOVA tests.
Taxonomic composition of the biofilms
The predominant phyla detected in all of the biofilms in
order of mean relative abundance were: Firmicutes, Bac-
teroidetes, Synergistetes, Fusobacteria, Proteobacteria and
Actinobacteria. Other phyla that were detected in minor
relative proportions, and not in every sample, included:
SR1, Spirochaetes, TM7 and Tenericutes. A total of 102ing those OTUs that were significantly differentially abundant
ll LDA scores >3.5).
Figure 4 Principal coordinates analysis of saliva and seven-day biofilms. Plots are based on community membership using the Jaccard
index (A) and community structure using the thetaYC calculator (B). Blue - biofilms; red - saliva. Labels indicate the panel number. A: PC1 = 8.6%
of variance, PC2 = 5.2% of variance. B: PC1 = 33.1% of variance, PC2 = 19.3% of variance.
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of which were: Veillonella, Streptococcus and Prevotella in
seven-day biofilms, and Streptococcus, Prevotella and Par-
vimonas in 14-day biofilms. Figure 6 shows the relative
abundances of the predominant genera detected in the
biofilms after seven and 14 days incubation. The relative
abundances of the predominant genera detected in the
saliva samples, from which biofilms were derived, areFigure 5 Linear Discriminant Analysis Effect Size (LEfSe) analysis show
between saliva and seven-day biofilms, ranked by effect size (all LDAshown in Additional file 4. A table detailing all of the taxa
identified down to the species level, and their relative pro-
portions in individual biofilm and saliva samples, can be
found in Additional file 5.
Discussion
This study has demonstrated that complex oral biofilms
derived from a natural saliva inoculum can be successfullying those OTUs that were significantly differentially abundant
scores >3.5).
Figure 6 Predominant genera detected in the biofilms. The graph shows the mean relative abundances of genera that were detected in
seven and 14-day biofilms derived from three panels. Genera shown are those with mean relative abundances of > 1%. Error bars show the
standard error of the mean (SEM).
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that the biofilms had a richness and diversity close to that
of the pooled saliva inocula, with a mean of 250 species-
level OTUs detected per biofilm sample compared to a
mean of 320 in saliva. There was a significant difference in
community membership and structure between the saliva
and the biofilms, with some OTUs detected in saliva not
present in the biofilms. This is not surprising because the
bacterial composition of saliva is known to differ to that of
dental plaque [32]. Saliva, however, does include represen-
tatives of the various surfaces found in the mouth and is
thus a useful inoculum for biofilms. Hydroxyapatite-
coated pegs were used for the purpose of mimicking the
teeth in order to obtain biofilms with a similar compos-
ition to plaque. Another possible reason for differences
between the inocula and the biofilms is that specific nutri-
ents or growth factors required by certain species could
have been absent in the growth medium used. A Brain-
Heart Infusion (BHI) based medium was chosen in this
study because it has been successfully used to cultivate a
broad range of fastidious and non-fastidious oral bacteria
[33]. The BHI was supplemented with mucin, vitamin K,
and haemin, as some oral species grow poorly or not at all
in the absence of one or more of these substances. For ex-
ample, a number of black-pigmented species of Prevotella
and Porphyromonas require haemin and vitamin K for
growth [34]. In addition, hog gastric mucin, a high mo-
lecular weight glycoprotein, has been shown to support
the growth of mixed communities of oral bacteria whenused as the principal source of carbon and energy [35].
Future work could investigate the use of different media,
such as an artificial saliva-based medium, with this model.
Another reason that certain salivary species may have
been lost is that the anaerobic atmosphere in which the
CBD was incubated would have selected against the
growth of aerobic species. The absence of host immune
cells and molecules in the second phase of growth may
also have had an impact on the community compos-
ition. Nevertheless, a highly diverse community of oral
bacteria was maintained which included the genera
known to be predominant in plaque and also a variety
of fastidious and uncultivated taxa, such as un-named
Bacteroidetes, Lachnospiraceae, Clostridiales and Pep-
tostreptococcaceae species.
Both saliva and biofilm samples were treated with
propidium monoazide prior to DNA extraction to avoid
detection of bacterial cells that were non-viable; this
method has been shown to prevent PCR amplification of
DNA from dead or damaged cells [19]. Interestingly,
there was no significant difference between PMA-treated
and untreated saliva in terms of community membership
and structure. This suggests that the vast majority of taxa
detected in the saliva samples were viable. This could be
due to the rapid processing of the samples performed in
order to avoid loss of cell viability. In addition, human sal-
iva has been shown to contain DNAse I produced by the
parotid glands [36], which could rapidly break down extra-
cellular bacterial DNA from dead cells.
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sity close to that detected in oral habitats, and that in-
clude previously uncultivated taxa, is a major strength of
this model over others. For instance, the well-established
Zürich biofilm model [14] has been developed with de-
fined inocula consisting of five, or more recently, 10 cul-
tivable species [37]. Defined biofilms consisting of a low
number of selected cultivable species are less representa-
tive of the in-vivo ecosystem and may, therefore, be less
accurate in predicting the efficacy of an active agent.
Another study recently reported the development of an
in-vitro biofilm model in which a natural saliva inoculum
was used and the composition of the samples determined
by pyrosequencing of 16S rRNA genes [38]. Whilst the
authors also reported a high microbial diversity, the incu-
bation times used were relatively short (up to 48 hours)
and this may explain why certain slow-growing oral
taxa, including Fretibacterium spp. and Tannerella spp.
were not detected, whilst streptococci were dominant
with S. vestibularis constituting approximately 40% of
the communities.
The taxonomic composition of the biofilms grown in
this study was similar to that of dental plaque. Strepto-
coccus, Veillonella and Prevotella were the predominant
genera detected in the biofilms, all of which have been
shown to be major constituents of plaque [39,40]. The
OTU detected with the highest mean relative abundance
in the biofilms was Veillonella parvula, which was also
detected with the highest rank abundance in an exten-
sive cloning and Sanger sequencing study of the human
oral microbiome [8]. In addition, periodontitis-associated
species, including the ‘red complex’: Porphyromonas gingi-
valis, Treponema denticola, Tannerella forsythia, and the
Gram-positive anaerobes Filifactor alocis and Parvimonas
micra, were all detected in the biofilms. These organisms
have been strongly associated with deep periodontal
pockets in individuals with severe chronic periodontitis
[9,41]. In the CBD model, P. micra was the organism most
strongly associated with 14-day biofilms. Species that had
a significantly lower relative abundance in 14-day biofilms
than 7-day biofilms included the streptococcal species S.
cristatus and S. salivarius / vestibularis, which have previ-
ously been associated with health [9,42]. Species among
the genera Neisseria and Rothia were detected at only very
low proportions in the biofilms, despite being abundant in
saliva. This is likely explained by the anaerobic incubation
of the CBD, as these organisms grow optimally under aer-
obic conditions [43,44]. It has been shown that the redox
potential (Eh) of dental plaque rapidly falls as the biofilm
develops in vivo [45]. In addition, experimental gingivitis
studies have shown that plaque accumulating in the
absence of oral hygiene supports the growth of increas-
ing numbers of anaerobic species, many of which are
gingivitis-associated [11,33]. This study aimed to growbiofilms that were similar in composition to biofilms
that would develop naturally in vivo without oral hygiene
intervention, and anaerobic incubation was chosen in
order to reproducibly obtain a biofilm typical of mature
plaque. However, future work could examine the compos-
ition of CBD oral biofilms grown under aerobic conditions
and compare them to those grown anaerobically. If using
the biofilm model to screen antimicrobial agents or oral
care product components, it would be useful to grow the
biofilms under both aerobic and anaerobic conditions in
order to determine the effect(s) of a given substance on as
diverse a range of oral taxa as possible. Future studies
could also compare the similarity of the in-vitro biofilms
to dental plaque biofilms that form naturally in vivo in the
same individuals abstaining from oral hygiene. This would
further confirm that this model generates oral biofilms
that are representative of those formed in vivo.
The results of this study showed that the bacterial
composition of the biofilms was highly reproducible for
sample replicates from different pegs derived from the
same saliva pool and incubated for the same length of
time. Moreover, the biofilms were similar in composition
when derived from the same panel at different time
points. After 14 days of incubation, when dissimilarity in
the biofilms might have been expected to increase, the
biofilms from the same panel clustered closely in the
PCoA plots. The differences between biofilms derived
from different panels was not surprising given the high
inter-individual variation in bacterial diversity found in
the normal human oral microbiome [46,47], although,
an attempt was made to reduce this variability by pool-
ing saliva from six individuals for use as the inoculum.
Hierarchical clustering of the biofilm samples in dendro-
grams indicated that the panel was the primary deter-
minant of community membership, but that incubation
time had a stronger influence on community structure.
This is likely to be because the relative abundances of
OTUs would be expected to change over time as the
biofilms mature. Due to the differences in both member-
ship and structure of biofilms derived from different
panels, the same panel should be used to provide the
saliva inoculum in future studies that aim to compare
biofilms grown under different conditions, or after ex-
posure to different challenges e.g. antimicrobial agents.
The reproducible biofilms that can be obtained using
this model will enable relatively small changes in bacter-
ial composition to be detected. This will be particularly
useful for assessing the impact of oral care products that
aim to manipulate or alter, rather than eradicate, plaque.
This includes active agents or bacteriocin-producing
probiotics that target particular taxa, or prebiotics that
could promote the growth of health-associated bacteria.
In the case of probiotics, the model could also be useful
in helping to predict whether or not a particular strain is
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addition to determining changes in the community com-
position of the biofilms, future work could also investigate
changes in community function using metagenomics,
metabolomics and metatranscriptomics, in response to
different active agents or changes in key environmen-
tal parameters.
Conclusions
This study has successfully developed an oral biofilm
model using the CBD seeded with a natural saliva inocu-
lum. The biofilms generated were highly complex and
comprised of microbial taxa that are commonly found in
dental plaque. In addition, their composition was shown
to be reproducible when derived from the pooled saliva
of the same panel of individuals. This model will therefore
be useful for screening novel antimicrobial agents and also
pre- or probiotics that aim to modify plaque composition.
Additional files
Additional file 1: Table showing the alpha diversity of pooled
saliva and biofilm samples. All samples were sub-sampled to 3023
sequences. P - panel; T - time point; S – saliva; SP – PMA-treated saliva;
7d - 7 days incubation; 14d - 14 days incubation; a, b, c - replicate.
Additional file 2: Dendrogram showing the similarity of biofilm and
saliva samples based on community membership (Jaccard index).
P - panel; T - time point; S – saliva; S_P – PMA-treated saliva; 7D - 7 days
incubation; 14D - 14 days incubation; a, b, c - replicate.
Additional file 3: Dendrogram showing the similarity of biofilm and
saliva samples based on community structure (thetaYC calculator).
P - panel; T - time point; S – saliva; S_P – PMA-treated saliva; 7D - 7 days
incubation; 14D - 14 days incubation; a, b, c - replicate.
Additional file 4: Bar chart of the predominant genera detected in
PMA-treated saliva samples. The chart shows the mean relative
abundances of genera that were detected in all three of the pooled
saliva samples from different panels. Genera shown are those with
mean relative abundances of > 1%. Error bars show the standard error of
the mean (SEM).
Additional file 5: Table showing the classification of sequences
to the species level in each sample. The table shows the relative
abundances of the phylotypes in the different samples. P - panel; T - time
point; S – saliva; S_P – PMA-treated saliva; 7D - 7 days incubation;
14D - 14 days incubation; a, b, c - replicate.
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